YOUR
Search

    23.10.2023

    Mehr Kontrolle für Gründer


    „Mehrstimmrechtsaktien erleben derzeit eine Renaissance. Sie brechen mit dem Grundsatz „eine Aktie, eine Stimme“ und erlauben auch bei relativ geringem Kapitaleinsatz ein hohes Maß an Kontrolle.“

     

    Dr. Barbara Mayer im Handelsblatt vom 24. Oktober 2023. Den gesamten Beitrag lesen Sie im PDF im Downloadbereich.

     

    [Translate to English:]
    ADVANT Beiten Advises Amphenol on Acquisit…
    Berlin, 16 October 2024 - The international law firm ADVANT Beiten has advised t…
    Read more
    ADVANT Beiten Advises Shareholder of 'Flam…
    Frankfurt, 9 September 2024 – The international law firm ADVANT Beiten has rende…
    Read more
    German Federal Court of Justice (BGH) conf…
    A vote cast contrary to a voting commitment is valid, even if all shareholders e…
    Read more
    All gone: retroactive withdrawal of the ma…
    The retroactive and complete withdrawal of a non-competition compensation in the…
    Read more
    General meeting: ban on bringing devices s…
    Shareholders may not generally be prohibited from merely carrying mobile phones …
    Read more
    ADVANT Beiten Advises the Herder Publishin…
    Freiburg, 6 August 2024 – The international law firm ADVANT Beiten has advised H…
    Read more
    ADVANT Beiten Advises Shareholders of Fisc…
    Freiburg, 5 August 2024 – The international law firm ADVANT Beiten has advised t…
    Read more
    ADVANT Beiten and ADVANT Nctm Advise BKW o…
    Freiburg, 17 July 2024 – The international law firm ADVANT Beiten has − together…
    Read more
    ADVANT Beiten Advises Dusseldorf-Based MedTech Company CUREosity Again on Financing Round
    Dusseldorf, 2 July 2024 – The international commercial law firm ADVANT Beiten has advised CUREosity GmbH, Dusseldorf, on a growth financing round which brought the medtech company a total of approximately …
    Read more